Literature DB >> 24048954

Disruptive behavior disorders: taking an RDoC(ish) approach.

R J R Blair1, Stuart F White, Harma Meffert, Soonjo Hwang.   

Abstract

The disruptive behavior disorders include Conduct Disorder (CD), Oppositional Defiant Disorder (ODD), and Attention Deficit Hyperactivity Disorder (ADHD). These disorders are highly comorbid with each other as well as with mood and anxiety disorders and personality disorders (particularly borderline personality disorder). The goal of this chapter is to consider these disorders from an RDoC(ish) approach. In other words, we will outline four functional processes and the behavioral implications of dysfunction within these processes. Moreover, we will briefly consider how dysfunction in one might increase the risk for the development of rather different behavioral problems that have been previously associated with rather different disorders. Our goal is to identify neurocognitive-based functional targets for treatment.

Entities:  

Mesh:

Year:  2014        PMID: 24048954     DOI: 10.1007/7854_2013_247

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  10 in total

1.  Methodological issues in the use of individual brain measures to index trait liabilities: The example of noise-probe P3.

Authors:  Emily R Perkins; James R Yancey; Laura E Drislane; Noah C Venables; Steve Balsis; Christopher J Patrick
Journal:  Int J Psychophysiol       Date:  2016-11-14       Impact factor: 2.997

Review 2.  The Neurobiology of Impulsive Aggression.

Authors:  Robert J R Blair
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-10-14       Impact factor: 2.576

3.  Applying a Cognitive Neuroscience Perspective to Disruptive Behavior Disorders: Implications for Schools.

Authors:  Patrick M Tyler; Stuart F White; Ronald W Thompson; R J R Blair
Journal:  Dev Neuropsychol       Date:  2018-02-12       Impact factor: 2.253

4.  Dysfunctional representation of expected value is associated with reinforcement-based decision-making deficits in adolescents with conduct problems.

Authors:  Stuart F White; Patrick M Tyler; Anna K Erway; Mary L Botkin; Venkata Kolli; Harma Meffert; Kayla Pope; James R Blair
Journal:  J Child Psychol Psychiatry       Date:  2016-04-08       Impact factor: 8.982

5.  Neural Correlates of the Propensity for Retaliatory Behavior in Youths With Disruptive Behavior Disorders.

Authors:  Stuart F White; Michelle VanTieghem; Sarah J Brislin; Isaiah Sypher; Stephen Sinclair; Daniel S Pine; Soonjo Hwang; R James R Blair
Journal:  Am J Psychiatry       Date:  2015-10-06       Impact factor: 18.112

Review 6.  Linking RDoC and HiTOP: A new interface for advancing psychiatric nosology and neuroscience.

Authors:  Giorgia Michelini; Isabella M Palumbo; Colin G DeYoung; Robert D Latzman; Roman Kotov
Journal:  Clin Psychol Rev       Date:  2021-03-24

Review 7.  Patient-reported outcomes in borderline personality disorder.

Authors:  Gregor Hasler; Christopher J Hopwood; Gitta A Jacob; Laura S Brändle; Thomas Schulte-Vels
Journal:  Dialogues Clin Neurosci       Date:  2014-06       Impact factor: 5.986

8.  Effectiveness of Stimulant Medications on Disruptive Behavior and Mood Problems in Young Children.

Authors:  Ian Parsley; Zhuo Zhang; Mark Hausmann; Arica Lerdahl; Brigette Vaughan; Ryan Edwards; Soonjo Hwang
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-08-31       Impact factor: 2.582

9.  Dysfunctional Social Reinforcement Processing in Disruptive Behavior Disorders: An Functional Magnetic Resonance Imaging Study.

Authors:  Soonjo Hwang; Harma Meffert; Michelle R VanTieghem; Stephen Sinclair; Susan Y Bookheimer; Brigette Vaughan; R J R Blair
Journal:  Clin Psychopharmacol Neurosci       Date:  2018-11-30       Impact factor: 2.582

10.  Neural Responses to Fluoxetine in Youths with Disruptive Behavior and Trauma Exposure: A Pilot Study.

Authors:  Soonjo Hwang; Unsun Chung; Yongmin Chang; Eunji Kim; Ji-Woo Suk; Harma Meffert; Christopher Kratochvil; Ellen Leibenluft; James Blair
Journal:  J Child Adolesc Psychopharmacol       Date:  2021-06-01       Impact factor: 2.576

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.